JPWO2023063376A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023063376A5 JPWO2023063376A5 JP2023554597A JP2023554597A JPWO2023063376A5 JP WO2023063376 A5 JPWO2023063376 A5 JP WO2023063376A5 JP 2023554597 A JP2023554597 A JP 2023554597A JP 2023554597 A JP2023554597 A JP 2023554597A JP WO2023063376 A5 JPWO2023063376 A5 JP WO2023063376A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- peptide compound
- composition
- less
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims 8
- -1 N-substituted amino Chemical group 0.000 claims 4
- FUJLYHJROOYKRA-QGZVFWFLSA-N O-lauroyl-L-carnitine Chemical compound CCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C FUJLYHJROOYKRA-QGZVFWFLSA-N 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 108010069514 Cyclic Peptides Proteins 0.000 claims 1
- 102000001189 Cyclic Peptides Human genes 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 239000004359 castor oil Substances 0.000 claims 1
- 235000019438 castor oil Nutrition 0.000 claims 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000008363 phosphate buffer Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021167912 | 2021-10-13 | ||
| JP2022075833 | 2022-05-02 | ||
| EP22192611 | 2022-08-29 | ||
| PCT/JP2022/038128 WO2023063376A1 (ja) | 2021-10-13 | 2022-10-12 | ペプチド化合物及び界面活性剤を含む組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023063376A1 JPWO2023063376A1 (https=) | 2023-04-20 |
| JPWO2023063376A5 true JPWO2023063376A5 (https=) | 2024-11-25 |
Family
ID=83546822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554597A Pending JPWO2023063376A1 (https=) | 2021-10-13 | 2022-10-12 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250302912A1 (https=) |
| EP (2) | EP4166133B1 (https=) |
| JP (1) | JPWO2023063376A1 (https=) |
| KR (1) | KR20240070705A (https=) |
| DK (1) | DK4166133T3 (https=) |
| TW (1) | TW202330014A (https=) |
| WO (1) | WO2023063376A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202446781A (zh) | 2011-12-28 | 2024-12-01 | 日商中外製藥股份有限公司 | 胜肽化合物之製造方法 |
| TW202506168A (zh) * | 2023-04-19 | 2025-02-16 | 日商中外製藥股份有限公司 | 包含環狀胜肽化合物及界面活性劑之組合物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH679277A5 (https=) * | 1989-02-09 | 1992-01-31 | Sandoz Ag | |
| US5912014A (en) * | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
| NZ328751A (en) * | 1997-09-16 | 1999-01-28 | Bernard Charles Sherman | Solid medicament containing an anionic surfactant and cyclosporin |
| TW200409644A (en) * | 2002-12-04 | 2004-06-16 | Bio Max Inc | Improved carrier system for cyclosporin pharmaceutical compositions |
| US8093207B2 (en) | 2005-12-09 | 2012-01-10 | Unigene Laboratories, Inc. | Fast-acting oral peptide pharmaceutical products |
| CA2839408A1 (en) * | 2011-06-14 | 2012-12-20 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
| TW202446781A (zh) | 2011-12-28 | 2024-12-01 | 日商中外製藥股份有限公司 | 胜肽化合物之製造方法 |
| IN2015DN03132A (https=) * | 2012-09-17 | 2015-10-02 | Tarix Pharmaceuticals Ltd | |
| DE102013219920A1 (de) * | 2013-10-01 | 2015-04-02 | Henkel Ag & Co. Kgaa | leistungsgesteigerte Haarbehandlungsmittel |
| WO2016004067A1 (en) * | 2014-06-30 | 2016-01-07 | Stealth Biotherapeutics Corp | Aromatic-cationic peptide formulations, compositions and methods of use |
| KR20250007021A (ko) * | 2017-06-09 | 2025-01-13 | 추가이 세이야쿠 가부시키가이샤 | N-치환 아미노산을 포함하는 펩타이드의 합성 방법 |
| CN110869544B (zh) | 2017-06-09 | 2024-03-08 | 中外制药株式会社 | 膜透过性高的环状肽化合物及包含其的文库 |
| BR112022007535A2 (pt) * | 2019-11-07 | 2022-07-12 | Chugai Pharmaceutical Co Ltd | Composto peptídico cíclico tendo ação inibitória de kras |
-
2022
- 2022-10-12 EP EP22200995.3A patent/EP4166133B1/en active Active
- 2022-10-12 JP JP2023554597A patent/JPWO2023063376A1/ja active Pending
- 2022-10-12 TW TW111138589A patent/TW202330014A/zh unknown
- 2022-10-12 DK DK22200995.3T patent/DK4166133T3/da active
- 2022-10-12 EP EP25190461.1A patent/EP4609875A3/en active Pending
- 2022-10-12 KR KR1020247015265A patent/KR20240070705A/ko active Pending
- 2022-10-12 US US18/699,488 patent/US20250302912A1/en active Pending
- 2022-10-12 WO PCT/JP2022/038128 patent/WO2023063376A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023063376A5 (https=) | ||
| FR2777891A1 (fr) | Derives d'aminoacides et procede pour leur production | |
| CN109562063A (zh) | 包含人胰高血糖素和末端接枝的共聚氨基酸的可注射水溶液形式的组合物 | |
| IL154893A0 (en) | Aliphatic nitrogen-containing cyclic compounds, methods for the preparation thereof and pharmaceutical compositions containing the same | |
| JPWO2023214509A5 (https=) | ||
| DK167842B1 (da) | Forbedrede vandige ranitidinformuleringer | |
| CN1092193C (zh) | 脯氨酰内肽酶抑制剂 | |
| EP4166133B1 (en) | Composition containing peptide compound and surfactant | |
| EP3915565A2 (en) | Xanthine oxidase inhibitor formulations | |
| ES2244529T3 (es) | Composiciones antibacterianas orales y metodo para la mejora de la absorcion gastrointestinal de los antibioticos de penemo o carbapenemo. | |
| JP3196106B2 (ja) | ロイコトリエンａ４ヒドロラーゼ阻害剤 | |
| US20180110822A1 (en) | Stable liquid pharmaceutical compositions of bortezomib | |
| JP2021521168A5 (https=) | ||
| WO2019123406A1 (en) | Novel formulations of vasopressin | |
| DK524686D0 (da) | ((((3-pyridinyl)methylen)amino)oxy)alkansyrer og estere deraf | |
| RU2005141496A (ru) | Азотсодержащие производные гетероарила | |
| KR102207372B1 (ko) | 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물 | |
| ATE151410T1 (de) | 1,2-diacylierte hydrazin-derivate und ihre verwendung als zelladhäsion-inhibitoren | |
| JPH0733666A (ja) | インドロカルバゾール誘導体の安定化法 | |
| WO2005023803A1 (en) | Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione | |
| JP2960350B2 (ja) | ヒト免疫不全ウイルスプロテアーゼ阻害剤、製造方法及び組成物 | |
| JPH10204096A (ja) | マンノピラノシル誘導体、それを有効成分とする薬剤およびその製造用中間体 | |
| RU2024114809A (ru) | Жидкие композиции аналогов амилина | |
| JPH0143733B2 (https=) | ||
| HK40004511A (en) | Compositions in the form of an injectable aqueous solution, comprising human glucagon and an end-grafted copolyamino acid |